XCL1 and neoplasm: In order to understand the reasons why the fusion chemokine Xcl1 enhances the anti-tumor activity driven by the E6E7 antigen, we conducted a detailed analysis of specific immune and innate immune cell subpopulations within tumors of mice following vaccine administration.